Actively Recruiting
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
Led by University of Southern California · Updated on 2025-12-18
50
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
U
University of Southern California
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This phase II trial evaluates manual lymphatic drainage breast massage for reducing treatment-related side effects in women undergoing radiation therapy after breast conserving surgery for breast cancer that has not spread to other parts of the body (localized). Breast conserving surgery can be an effective treatment option for early stage breast cancer, but it can also be associated with side effects including fluid collection in tissues/swelling (lymphedema), pain, reduced quality of life, and poorer body image. Manual lymphatic drainage is a gentle massage technique used to reduce swelling. It may be a safe and effective way to reduce treatment-related side effects in women receiving radiation therapy after surgery for localized breast cancer.
CONDITIONS
Official Title
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female with native breasts and localized breast cancer who have had lumpectomy and will receive whole breast radiation therapy with or without nodal irradiation using standard fractionation or moderate hypofractionation
- Age 18 years or older
- Ability to understand and willing to sign written informed consent in English or Spanish
You will not qualify if you...
- Diagnosis of chronic inflammatory illness or collagen vascular disorder such as scleroderma, lupus, rheumatoid arthritis, or fibromyalgia
- Uncontrolled illness including active infection, symptomatic heart failure, unstable angina, unstable arrhythmia, or psychiatric/social conditions limiting study compliance
- Unable to provide written informed consent in English or Spanish
- Receiving ultra-hypofractionation or partial breast or chest wall radiation therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033
Actively Recruiting
Research Team
K
Kimberly Arieli, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here